3 Day Blinds Inc.

Private Company, Headquarters Location
2220 E Cerritos Ave., Anaheim, CA 92806-5709, United States
(800)800-3329, (714)634-4600, (714)634-1041 fax, http://www.3dayblinds.com

Primary SIC: Miscellaneous Homefurnishings Stores, Primary NAICS: All Other Home Furnishings Stores
Description: Retail: Manufactures and installs window coverings.

View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!

3 Day Blinds Inc., News and Information

Study findings from E.A. Macgregor et al provide new insights into adverse drug reactions.
Women's Health Weekly; 11/12/2009; 967 words; ...Pharmaceuticals Inc., Chadds...efficacy of a 6-day regimen of...over 1 to 3 perimenstrual...controlled double-blind parallel trial...started -2 days to +3 (Study 1...Study 2) days relative to the first day of menses...was given 2 days before anticipated...request ...

Study data from C.A.L. Gaffaney and co-authors update knowledge of women's health.(Clinical report)
Women's Health Weekly; 11/12/2009; 908 words; ...performed a randomized, double-blind, placebo-controlled study...mu g or placebo daily for 3 days unless the subject developed...of oral misoprostol over 3 days to women with prolonged pregnancies...is: Thieme Medical Publ Inc., 333 Seventh Avenue...

Hyperion Therapeutics Announces First Patient Enrolled in Pivotal Trial in Patients With Urea Cycle Disorders.(Clinical report)
Biotech Week; 11/11/2009; 1627 words; ...randomized, double-blind, cross-over study...under the curve on Days 14 and 28 (last day of each treatment...phenylbutyrate (~ 3.5 teaspoons) delivers...and Ucyclyd Pharma, Inc., a subsidiary of...Hyperion Therapeutics, Inc.). BUPHENYL is...of Ucyclyd Pharma, Inc. Full ...

Results of Phase I Study Show Novel, Investigational PA65020 Compound Significantly Decreased Risk of Upper GI Damage in Healthy Adults.
Biotech Week; 11/11/2009; 1552 words; POZEN Inc. (NASDAQ: POZN) announced...randomized, double-blind study highlighted that...science (see also POZEN Inc.). "These findings...twice daily. Following 28 days of therapy, 15% of the...treatment group had Grade 3 or 4 Lanza scores (P...these complications at day 28. No serious ...

Forest Laboratories, Inc. and Gedeon Richter Announce Positive Results from a Phase IIb Study of Cariprazine for the Treatment of Schizophrenia.
Clinical Trials Week; 11/9/2009; 1837 words; ...Forest Laboratories, Inc. (NYSE: FRX) and...Forest Laboratories, Inc.). For the primary...to initiate Phase 3 trials for both indications...therapy for up to seven days, a total of 732 patients...d cariprazine, 3.0 mg/d cariprazine...weeks of the double-blind treatment. ...

Why Purchase This Company Profile?

  • Sales prospecting
  • Competitive analysis
  • Vendor & supplier evaluation
  • Customer evaluation and analysis
  • Strategic planning

Need More Information?

Start a new search

Tell Us What You Think

Take our short survey to tell us what would make Goliath more valuable to you.

Add Your Company Information to Goliath
If your company does not appear in Goliath, click here to add it.

Update Your Company Information
If your company information has changed or is not correct,
click here to let us know.